CN Patent

CN104721825B — 具有确定比表面积的二酮哌嗪颗粒

Assigned to Mannkind Corp · Expires 2019-04-12 · 7y expired

What this patent protects

本申请涉及具有确定比表面积的二酮哌嗪颗粒以及包含二酮哌嗪微粒的组合物。本文公开了比表面积小于约67m 2 /g的二酮哌嗪微粒。所述二酮哌嗪微粒可以是富马酰基二酮哌嗪并且可以包含诸如胰岛素的药物。

USPTO Abstract

本申请涉及具有确定比表面积的二酮哌嗪颗粒以及包含二酮哌嗪微粒的组合物。本文公开了比表面积小于约67m 2 /g的二酮哌嗪微粒。所述二酮哌嗪微粒可以是富马酰基二酮哌嗪并且可以包含诸如胰岛素的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN104721825B
Jurisdiction
CN
Classification
—
Expires
2019-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Mannkind Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.